Latest Working Capital News

Blue Star Helium has successfully completed its 2025 Galactica drilling program, securing a major permit for CO2 processing and preparing to start commercial helium production in the second half of 2025. The company also raised $4.54 million to fund ongoing development.

Mad Paws Holding Limited reported modest revenue growth and improved cash flow in Q4 2025, while progressing a significant acquisition deal with Rover Group and divesting its Pet Chemist business.

Boab Metals has taken a major step forward in developing its Sorby Hills Lead-Silver-Zinc Project by acquiring the DeGrussa Processing Plant and completing a $6 million capital raise, positioning the company for a Final Investment Decision later this year.

Control Bionics capped a record FY25 with 15% revenue growth, driven by US market gains and expanding NeuroNode and NeuroStrip technologies. The company also achieved a US profitability milestone and is close to finalizing key distribution partnerships.

CZR Resources has secured shareholder and regulatory approval to sell its Robe Mesa iron ore project for A$75 million, positioning the company to focus on promising gold and base metal exploration in Western Australia.

Brightstar Resources has delivered a strong Definitive Feasibility Study for its Laverton and Menzies Gold Projects, targeting over 338,000 ounces of gold with promising financial returns, while ramping up underground mining operations and securing $50 million in capital.

Blue Star Helium has raised A$4.5 million through a strategic institutional placement to fund the final stages of its Galactica helium project, aiming for production by late 2025.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

TechGen Metals Limited has announced a fully underwritten $2.57 million rights issue to accelerate exploration and drilling at its Blue Devil and Mt Boggola copper-gold projects in Western Australia.

Alexium International Group faced a tough FY25 with declining sales amid a soft US mattress market but is poised for growth in FY26 thanks to technological advances and strategic funding support.

Fluence Corporation Limited reported a positive net operating cash flow of US$5.1 million for Q2 2025, boosting its cash reserves to US$12.7 million and maintaining solid liquidity through revolving credit and loan facilities.

Lotus Resources is on track to restart uranium production at its Kayelekera project in Malawi by Q3 2025, backed by binding offtake contracts covering nearly 4 million pounds of uranium and a robust cash position.